Aloe Vera and Curcumin Nanoparticles Show Promise for Alzheimer's Treatment

Jim Crocker
16th July, 2024

Aloe Vera and Curcumin Nanoparticles Show Promise for Alzheimer's Treatment

Image Source: Natural Science News, 2024

Key Findings

  • Researchers from Banasthali Vidyapith developed Aloe vera-coated curcumin nanoparticles to treat Alzheimer's disease in mice
  • The nanoparticles improved memory and learning in Alzheimer's-induced mice within seven days
  • The formulation reduced oxidative stress markers and mitigated typical Alzheimer's brain changes like amyloid plaques and neurofibrillary tangles
Alzheimer's disease (AD) remains a significant challenge in the medical field, with current treatments unable to halt its progression or provide a cure[2]. Recent research from Banasthali Vidyapith has explored a novel approach by using Aloe vera-coated curcumin encapsulated nanoparticles to mitigate AD progression in mice[1]. This study examines the potential of this nanoformulation by evaluating behavioral changes, biochemical markers, and histopathological alterations. The green synthesis method was employed to create the Aloe vera-coated curcumin nanoparticles. Characterization techniques such as percentage encapsulation efficacy, UV-visible spectroscopy, Dynamic Light Scattering (DLS), Fourier Transform Infrared Spectroscopy (FT-IR), Field Emission Scanning Electron Microscopy (FESEM), and Energy Dispersive X-ray (EDX) analysis confirmed the stability and efficacy of the formulation. The nanoparticles exhibited a mean diameter of 76.12 nm ±1.23, a polydispersity index (PDI) of 0.313 ± 0.02, a zeta potential of 6.27 ± 0.65 mV, and an encapsulation efficiency between 90% and 95%. In vivo assessments were conducted using various behavioral tests, including the Morris water maze, Y-maze, and novel object recognition assay. These tests are standard methods to evaluate learning capacity and memory in animal models. The results showed that the nanoformulation significantly decreased the transfer latency, indicating improved cognitive function within seven days. This is particularly promising as it suggests that the formulation can enhance memory and learning in AD-induced mice. The biochemical benefits of the nanoformulation were also notable. Oxidative stress markers, which are indicators of cellular damage, were significantly reduced. This aligns with previous findings that curcumin has strong antioxidant properties[3]. Moreover, histological studies revealed that the formulation mitigated the typical pathological changes associated with AD, such as amyloid plaques and neurofibrillary tangles. The encapsulation of curcumin in nanoparticles addresses a significant limitation of curcumin's therapeutic use—its low bioavailability[4]. By enhancing its bioavailability, the formulation ensures that a higher concentration of curcumin reaches the target sites in the brain. This is critical for exerting its neuroprotective effects. Previous studies have shown that nanoformulations of curcumin can significantly improve its anti-cancer and anti-bacterial properties[4], and this study extends these benefits to neurodegenerative diseases like AD. Furthermore, the use of Aloe vera as a coating material adds an additional layer of therapeutic benefit. Aloe vera is known for its anti-inflammatory and antioxidant properties, which can synergize with curcumin to provide a more comprehensive treatment approach. Combining natural remedies with advanced drug delivery systems, as demonstrated in this study, offers a promising strategy for treating complex diseases like AD[2]. In conclusion, the Aloe vera-coated curcumin encapsulated nanoparticles developed by Banasthali Vidyapith show significant potential as a therapeutic intervention for Alzheimer's disease. The formulation not only improves cognitive function but also offers biochemical and histopathological benefits. This study builds on previous research highlighting the benefits of curcumin in various diseases[3] and demonstrates the effectiveness of advanced drug delivery systems in enhancing its therapeutic efficacy. Further research, including clinical trials, will be crucial to validate these findings and potentially bring this promising treatment strategy to patients.

MedicineHealthBiochem

References

Main Study

1) Therapeutic potential of Aloe vera-coated curcumin encapsulated nanoparticles in an Alzheimer-induced mice model: behavioural, biochemical and histopathological evidence.

Published 15th July, 2024

https://doi.org/10.1080/02652048.2024.2373715

Related Studies

2) Natural remedies for Alzheimer's disease: A systematic review of randomized controlled trials.

https://doi.org/10.1007/s11011-022-01063-9

3) Benefits of curcumin in brain disorders.

https://doi.org/10.1002/biof.1533

4) Curcumin Encapsulated into Biocompatible Co-Polymer PLGA Nanoparticle Enhanced Anti-Gastric Cancer and Anti-Helicobacter Pylori Effect.

https://doi.org/10.31557/APJCP.2022.23.1.61


Related Articles

An unhandled error has occurred. Reload 🗙